• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染和接种疫苗后细胞因子指纹的差异——我们能从 COVID-19 中学到什么?

Cytokine fingerprint differences following infection and vaccination - what can we learn from COVID-19?

机构信息

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Division of Pulmonary Medicine, Barzilai University Medical Center, Ashkelon, and Ben-Gurion University of the Negev, Beer-Sheva, Israel.

出版信息

Eur Cytokine Netw. 2024 Feb 1;35(1):13-19. doi: 10.1684/ecn.2024.0494.

DOI:10.1684/ecn.2024.0494
PMID:38909356
Abstract

COVID-19 vaccination and acute infection result in cellular and humoral immune responses with various degrees of protection. While most studies have addressed the difference in humoral response between vaccination and acute infection, studies on the cellular response are scarce. We aimed to evaluate differences in immune response among vaccinated patients versus those who had recovered from COVID-19. This was a prospective study in a tertiary medical centre. The vaccinated group included health care workers, who had received a second dose of the BNT162b2 vaccine 30 days ago. The recovered group included adults who had recovered from severe COVID-19 infection (<94% saturation in room air) after 3-6 weeks. Serum anti-spike IgG and cytokine levels were taken at entry to the study. Multivariate linear regression models were applied to assess differences in cytokines, controlling for age, sex, BMI, and smoking status. In total, 39 participants were included in each group. The mean age was 53 ±14 years, and 53% of participants were males. Baseline characteristics were similar between the groups. Based on multivariate analysis, serum levels of IL-6 (β=-0.4, p<0.01), TNFα (β=-0.3, p=0.03), IL-8 (β=-0.3, p=0.01), VCAM-1 (β=-0.2, p<0.144), and MMP-7 (β=-0.6, p<0.01) were lower in the vaccinated group compared to the recovered group. Conversely, serum anti-spike IgG levels were lower among the recovered group (124 vs. 208 pg/mL, p<0.001). No correlation was identified between antibody level and any of the cytokines mentioned above. Recovered COVID-19 patients had higher cytokine levels but lower antibody levels compared to vaccinated participants. Given the differences, these cytokines might be of value for future research in this field.

摘要

COVID-19 疫苗接种和急性感染会引起不同程度的细胞和体液免疫反应。虽然大多数研究都集中在疫苗接种和急性感染之间的体液反应差异上,但关于细胞反应的研究却很少。我们旨在评估接种疫苗的患者与从 COVID-19 中康复的患者之间免疫反应的差异。这是一项在三级医疗中心进行的前瞻性研究。接种组包括医护人员,他们在 30 天前接受了第二剂 BNT162b2 疫苗。康复组包括在 3-6 周后从严重 COVID-19 感染中康复(室内空气饱和度<94%)的成年人。在进入研究时,采集了血清抗刺突 IgG 和细胞因子水平。应用多元线性回归模型评估细胞因子的差异,控制年龄、性别、BMI 和吸烟状况。共有 39 名参与者被纳入每个组。平均年龄为 53±14 岁,53%的参与者为男性。两组间的基线特征相似。基于多变量分析,与康复组相比,接种组血清中 IL-6(β=-0.4,p<0.01)、TNFα(β=-0.3,p=0.03)、IL-8(β=-0.3,p=0.01)、VCAM-1(β=-0.2,p<0.144)和 MMP-7(β=-0.6,p<0.01)水平较低。相反,康复组的血清抗刺突 IgG 水平较低(124 与 208 pg/mL,p<0.001)。抗体水平与上述任何细胞因子之间均未发现相关性。与接种疫苗的参与者相比,康复的 COVID-19 患者的细胞因子水平更高,但抗体水平更低。鉴于这些差异,这些细胞因子可能对该领域的未来研究具有价值。

相似文献

1
Cytokine fingerprint differences following infection and vaccination - what can we learn from COVID-19?感染和接种疫苗后细胞因子指纹的差异——我们能从 COVID-19 中学到什么?
Eur Cytokine Netw. 2024 Feb 1;35(1):13-19. doi: 10.1684/ecn.2024.0494.
2
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.BNT162b2、BBIBP-CorV 和 Gam-COVID-Vac 疫苗的免疫原性以及自然感染 SARS-CoV-2 后的免疫反应-来自塞尔维亚诺维萨德的一项比较研究。
PLoS One. 2022 Feb 2;17(2):e0263468. doi: 10.1371/journal.pone.0263468. eCollection 2022.
3
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.智利科兴和国药疫苗接种后动态 IgG 血清阳性率:哨点监测研究。
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
4
Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.以色列卫生保健工作者中,第三剂 BNT162b2 疫苗接种与 SARS-CoV-2 感染发生率的关联。
JAMA. 2022 Jan 25;327(4):341-349. doi: 10.1001/jama.2021.23641.
5
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
6
Investigation of Anti-SARS-CoV-2-specific IgG Levels in Breast Milk after Vaccination or COVID-19 Infection.接种疫苗或感染 COVID-19 后母乳中抗 SARS-CoV-2 特异性 IgG 水平的研究。
Am J Perinatol. 2024 May;41(S 01):e3085-e3090. doi: 10.1055/a-2192-0655. Epub 2023 Oct 16.
7
Evaluation of Humoral Immune Response after SARS-CoV-2 Vaccination Using Two Binding Antibody Assays and a Neutralizing Antibody Assay.评价两种结合抗体检测试剂盒和中和抗体检测试剂盒在评估 SARS-CoV-2 疫苗接种后的体液免疫应答中的应用。
Microbiol Spectr. 2021 Dec 22;9(3):e0120221. doi: 10.1128/Spectrum.01202-21. Epub 2021 Nov 24.
8
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History.根据 BNT162b2 疫苗接种和感染史,抗 SARS-CoV-2 免疫球蛋白同种型和对病毒变异体的中和活性。
Front Immunol. 2021 Dec 17;12:793191. doi: 10.3389/fimmu.2021.793191. eCollection 2021.
9
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
10
Immunogenicity of Two Doses of BNT162b2 mRNA COVID-19 Vaccine with a ChAdOx1-S Booster Dose among Navy Personnel in Mexico.墨西哥海军人员中两剂BNT162b2 mRNA新冠疫苗加一剂ChAdOx1-S加强针的免疫原性
Viruses. 2024 Apr 1;16(4):551. doi: 10.3390/v16040551.

引用本文的文献

1
Altered Circulating Cytokine Profile Among mRNA-Vaccinated Young Adults: A Year-Long Follow-Up Study.mRNA 疫苗接种的年轻成年人循环细胞因子谱的改变:一项为期一年的随访研究。
Immun Inflamm Dis. 2025 Apr;13(4):e70194. doi: 10.1002/iid3.70194.
2
Obesity does not influence SARS-CoV-2 humoral vaccine immunogenicity.肥胖不影响新型冠状病毒2型的体液疫苗免疫原性。
NPJ Vaccines. 2024 Nov 18;9(1):226. doi: 10.1038/s41541-024-01022-8.